Clinitech Laboratory Logo

Clinitech Laboratory Limited

CTLLAB

96-96

per share
Bidding Dates
25-29 Jul
Min. Investment
₹1,15,200.00
Lot Size
1200 shares
Issue Size
₹5.78 Cr
IPO Timeline
Bidding starts
25 Jul ‘24
Bidding ends
29 Jul ‘24
Allotment finalisation*
30 Jul ‘24
Refund initiation*
31 Jul ‘24
Demat transfer
31 Jul ‘24
Listing
01 Aug ‘24
* Refund is a 7-10 days process. If you don’t get refund then please contact your bank.

About Clinitech Laboratory Limited

Founded in 1990, Clinitech Laboratory Limited operates a network of eight diagnostic centers strategically located in Thane and Navi Mumbai, offering a comprehensive range of diagnostic and healthcare tests. Annually, they conduct more than 3 lakh tests in their NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs, equipped with advanced technology and high-end equipment. These tests span across various disciplines including Biochemistry, Immunology, Hematology, Molecular Biology, Serology, Microbiology, and Histopathology, enabling precise diagnosis and effective treatment planning.

Clinical pathology forms the core of their services, focusing on the analysis of bodily fluids and tissues to diagnose diseases and conditions. Their laboratories perform crucial tests such as blood tests, urine analysis, and tissue biopsies, which are essential in understanding the underlying causes of symptoms and guiding healthcare decisions. Their team of clinical pathologists plays a pivotal role in interpreting test results and providing valuable insights to aid in patient care.

Looking ahead, they anticipate potential competition from new entrants with established business networks, posing threats to their market share. Such competitors may leverage larger financial resources for enhanced marketing and service delivery capabilities. Despite these challenges, Clinictech Laboratory Limited is poised to uphold its leadership in diagnostic and healthcare services through strategic management practices, technological innovation, and a steadfast commitment to meeting the evolving needs of their clientele.

As Clinitech Laboratory Limited prepares for its Initial Public Offering (IPO), the proceeds from the Fresh Issue will be allocated towards critical objectives:

  1. Expansion of Diagnostic Centres; 
  2. General Corporate Purposes 

IPO analysis

Registrar information
Name
Bigshare Services Pvt Ltd
Phone number
+91-22-6263 8200
Email ID
ipo@bigshareonline.com
Red herring prospectus
View documents submitted by company in filing to understand more details about them.

Interested in investing in an IPO?

Open free Demat + trading account and join our 1 crore+ successful users.
Already have an account with Upstox?
Login